Venture CapitalData & Analysis

This article is part one of a series on VC perspectives and how VCs are responding and supporting their portfolios in response to the realities of COVID-19. If you would like to provide commentary, please contact us here. Breezing past trade disputes and political volatility, yield-curves and domestic energy conflicts, venture capital in Canada is

On December 19, 2019, Alberta-based Decisive Farming announced it had been acquired by Vancouver-headquartered TELUS. The terms of the deal were not disclosed. CVCA members, McRock Capital, were early investors in the company and the acquisition represents a successful exit for the fund. According to AgFunderNews, Decisive Farming combines precision agronomics, crop marketing, and information

This article is part two of a two-part series providing insights from leading women in Canadian private capital in celebration of International Women’s Day. The CVCA will be publishing its 2019 year-end report next week and the preliminary numbers show Canadian venture capital heading towards another record year for investment and private equity continuing its

Photo: mnubo Co-founders (left to right): Frédéric Bastien, Jean-Charles Beaudin, Jean-Christophe Cimino, Aditya Pendyala On July 12, Montreal-based mnubo Inc. announced it had been acquired by Massachusetts-based Aspen Technologies for CAD $102M. CVCA members White Star Capital and McRock Capital had been early investors in mnubo and the acquisition represents a successful exit for the funds.

In a CVCA Central first, we spoke with Lumira Ventures to go behind the scene of three of their recent deals. On April 8, Michigan-based medical device company HistoSonics, announced it had raised USD $54 million in a Series C financing including participation from Lumira Ventures. HistoSonics is a venture-backed medical device company developing a

On April 18, Toronto-based VC fund, iGan Partners, announced it had raised CAD $100M for its first fund, iGan Fund I; surpassing its initial goal of CAD $50M. The fund is focused on the health technology sector which includes digital health, medical devices, healthcare IT and AI. The fund will also provide diversified exposure to